Risk Stratification-directed NAC for Prevention of Poor Hematopoietic Reconstitution

Clinical trial NCT03967665 · UNKNOWN

Trial details

NCT number: NCT03967665
Sponsor: Peking University People's Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Stem Cell Transplant Complications

Start date: 2018-10-01
Primary completion: 2021-09-05
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.